Dec 15, 2021 / 03:00PM GMT
Sara Parigian - LifeSci Advisors, LLC - VP of KOL Strategy & Management
As a reminder, this conference is being recorded, and a replay will be made available on the MeiraGTx website, following the event.
I would now like to turn the call over to your host, Zandy Forbes, President and Chief Executive Officer of MeiraGTx. Please go ahead, Zandy.
Alexandria Forbes - MeiraGTx Holdings plc - CEO, President & Director
Thank you very much.
Good morning. I'm Zandy Forbes, the President and CEO of MeiraGTx, and thank you for joining us today. We're going to present some of the unique technologies that we've built Meira and discuss how these tools can transform the field of genetic medicine. In particular, I'm going to talk about technologies that allow us for the first time to precisely and specifically control the activity of genetic medicines, using orally dosed pills. I'll show how we're applying these technologies to some of the intractable problems that small molecules, injectable biologic drugs and unregulated gene therapies have not
MeiraGTx Holdings PLC R&D Day (Virtual) Transcript
Dec 15, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers